SOLUTIONS TO ADDRESS THE GLOBAL HEALTH CRISES POSED BY INFECTIOUS DISEASE

Infectious Diseases

The aggressive nature of infectious diseases requires a rapid response that Fortrea is well-prepared to meet

With worldwide health threats on the rise, Fortrea’s global team understands the realities of local barriers

Our regulatory and market access teams collaborate to achieve emergency use authorizations when needed

Attacking opportunistic pathogens.

The world is running out of effective treatments for common infections, including urinary tract, wound, bloodstream and sexually transmitted infections, which are often fatal in vulnerable and underserved populations. Similarly, emerging and re-emerging infectious diseases such as COVID-19 (SARS-CoV- 2) and tuberculosis continue to pose a global public health threat. With research rapidly advancing and new paradigms for disease prevention and treatment, the competitive landscape for new vaccines and therapies in development requires rapid testing to provide both medical and economic proof of efficacy. We have successfully partnered with biopharmaceutical companies to bring multiple assets to market, including three of the last four antibiotics, as well as vaccines against COVID-19. Fortrea is relentless in its promise to provide you guidance and to help deliver solutions made real.

Applying insight and expertise.

Our infectious disease and vaccine experts are among the most knowledgeable and skilled in the industry with expertise in clinical development of products to prevent and treat bacterial, viral, fungal and parasitic infections. In fact, Fortrea’s teams have worked on hundreds of infectious disease and vaccine studies — including COVID-19 — and we can leverage this expertise to shape new opportunities for you.

Decoding the complexities of vaccine and anti-infective drug development.

From acquiring information on the immunogenicity of vaccine antigens to determining characteristics critical to a vaccine’s success, we make sure each molecule regulatory submission is sound. And, if rapid project initiation of large global trials with microbiology services is needed, we have the expertise to deliver against your critical milestones swiftly.

Your needs. Our solutions.

As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma, medical device, and diagnostic companies to drive healthcare innovation and improve the lives of patients worldwide.